Blood test study for Parkinson’s stages
Treatments studied
Part of Brain & nervous system clinical trials.
This study measures blood biomarkers (measurable substances in blood) in people with Parkinson’s at different stages. It may help doctors understand how Parkinson’s changes over time and could guide future testing or treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson’s disease that is considered “idiopathic” (not caused by another known condition).
- Your age is between 18 and 80 years.
- You can sign an informed consent form to join the study.
- You are not pregnant (if you could become pregnant, you should be sure you are not currently pregnant).
- You do not have an active inflammatory or autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses new technology (like sensors or apps) to help diagnose and monitor Parkinson's disease early. Researchers want to see if a simple, widespread healthcare service model can improve care. Both people with Parkinson's and healthy volunteers are needed.
This study looks for a new blood marker that could help doctors detect Parkinson’s disease earlier. Depending on your diagnosis and treatment status, your blood may be compared with other people’s to see how well the test works.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study looks at how blood pressure is controlled in people with Parkinson's disease, especially those who feel dizzy when standing up. It may help doctors understand and treat this problem better.
This trial looks at how analyzing hand movements might help doctors tell the difference between Parkinson's disease and other similar conditions early on. It may help improve diagnosis so patients get the right care sooner.
This study tests whether a protein in colon tissue can help diagnose Parkinson's disease. People with Parkinson's who already need a routine colonoscopy may participate.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.